Abstract
Minimal residual disease (MRD) in acute leukemia is defined as the relatively few (1 – 1010) leukemic cells which have survived successful remission-induction chemotherapy. In human acute myelocytic leukemia (AML) there is a significant lack of knowledge on the degree and biological behavior of MRD. However, this is the population of AML cells that determines the failure in the majority of patients:a relapse.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hagenbeek A, Van Bekkum DW (eds) (1977) Proceedings of an international workshop on Comparative evaluation of the L5222 and the BNML rat leukaemia models and their relevance for human acute leukaemia. Leuk Res 1:75–256
Hagenbeek A, Martens ACM (1985) Detection of minimal residual disease in acute leukemia:possibilities and limitations. Eur J Cancer Clin Oncol 21:389–394
Martens ACM, Hagenbeek A (1985) Detection of minimal disease in acute leukemia using flow cytometry:studies in a rat model for human acute leukemia. Cytometry 6:342–347
Martens ACM, Johnson RJ, Kaizer H, Hagenbeek A (1984) Characteristics of a monoclonal antibody (Rml24) against acute myelocytic leukemia cells. Exp Hematol 12:667–672
Martens ACM, Schultz FW, Hagenbeek A (1987) Nonhomogeneous distribution of leukemia in the bone marrow during minimal residual disease. Blood 70:1073–1077
Van Bekkum DW, Hagenbeek A (1977) Relevance of the BN leukemia as a model for human acute myeloid leukemia. Blood Cells 3:565–572
Visser JWM, Martens ACM, Hagenbeek A (1986) Detection of minimal residual disease in acute leukemia by flow cytometry. Ann NY Acad Sci 468:268–276
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hagenbeek, A., Martens, A.C.M. (1990). Minimal Residual Disease in Acute Leukemia:Lessons Learned from Animal Models. In: Büchner, T., Schellong, G., Hiddemann, W., Ritter, J. (eds) Acute Leukemias II. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74643-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-74643-7_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50984-4
Online ISBN: 978-3-642-74643-7
eBook Packages: Springer Book Archive